Biomaterial Database

[Visceral calcinosis induced by intravenous phosphate perfusions in myelomatous hypercalcemia]. 1969

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

UI	MeSH Term	Description	Entries
D007684	Kidney Tubules	Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER.	Kidney Tubule,Tubule, Kidney,Tubules, Kidney
D008297	Male		Males
D008558	Melphalan	An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen.	Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D009101	Multiple Myeloma	A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.	Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D010477	Perfusion	Treatment process involving the injection of fluid into an organ or tissue.	Perfusions
D010710	Phosphates	Inorganic salts of phosphoric acid.	Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011650	Pulmonary Alveoli	Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place.	Alveoli, Pulmonary,Alveolus, Pulmonary,Pulmonary Alveolus
D002114	Calcinosis	Pathologic deposition of calcium salts in tissues.	Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D002118	Calcium	A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.	Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003520	Cyclophosphamide	Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.	(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

[Polyvisceral metastatic calcinosis after inorganic phosphate perfusion for myelomatous acute hypercalcemia].

September 1970, Journal d'urologie et de nephrologie,

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

[Treatment of hypercalcemia of myelomatous origin with intravenous diphosphonates].

December 1983, Presse medicale (Paris, France : 1983),

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

[Intravenous perfusions].

February 1974, Revue de l'infirmiere,

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

Intravenous phosphate solution for treatment of hypercalcemia.

September 1974, The Medical letter on drugs and therapeutics,

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

[Viomycin in intravenous perfusions].

January 1961, Revue de la tuberculose,

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

Calcinosis cutis with siliconomas complicated by hypercalcemia.

January 2005, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

Cutaneous calcinosis--an unusual complication of intravenous phosphate administration.

July 1993, Clinical and experimental dermatology,

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

[Intravenous perfusions: solutions, medicines].

November 1983, Revue de l'infirmiere,

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

[Amphotericin in intravenous perfusions in moniliasis].

January 1970, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,

P Deshayes, and D Levillain, and M Cauvin, and J Forthomme

[Some risks of intravenous perfusions].

December 1962, Concours medical,